Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer - Related Studies

Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer

This study is currently recruiting participants.

Study NCT00068601. Last updated on November 14, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Breast Cancer
		Cancer-Related Problem/Condition

2	Additional conditions recognized in this trial
		Breast Neoplasms
		Ovarian Failure, Premature

3	More general conditions related to this trial
		Adnexal Diseases
		Breast Diseases
		Endocrine System Diseases
		Genital Diseases, Female
		Gonadal Disorders
		Neoplasms
		Neoplasms by Site
		Ovarian Diseases
		Skin Diseases

4	Interventions listed in this trial
		cyclophosphamide
		goserelin

5	More general drug interventions related to this trial
		Alkylating Agents
		Antineoplastic Agents
		Antineoplastic Agents, Alkylating
		Antineoplastic Agents, Hormonal
		Antirheumatic Agents
		Immunologic Factors
		Immunosuppressive Agents
		Molecular Mechanisms of Pharmacological Action
		Myeloablative Agonists
		Pharmacologic Actions
		Physiological Effects of Drugs
		Therapeutic Uses

6	Sponsors listed in this trial
		Southwest Oncology Group
		National Cancer Institute (NCI)
		Cancer and Leukemia Group B
		Eastern Cooperative Oncology Group
		International Breast Cancer Study Group